CN108765411A - A kind of tumor classification method based on image group - Google Patents
A kind of tumor classification method based on image group Download PDFInfo
- Publication number
- CN108765411A CN108765411A CN201810566664.2A CN201810566664A CN108765411A CN 108765411 A CN108765411 A CN 108765411A CN 201810566664 A CN201810566664 A CN 201810566664A CN 108765411 A CN108765411 A CN 108765411A
- Authority
- CN
- China
- Prior art keywords
- heterogeneous
- lesion
- cluster
- image
- area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 56
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 39
- 230000003902 lesion Effects 0.000 claims abstract description 77
- 239000013598 vector Substances 0.000 claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 9
- 238000003205 genotyping method Methods 0.000 claims abstract description 9
- 230000004069 differentiation Effects 0.000 claims abstract description 5
- 238000000605 extraction Methods 0.000 claims description 25
- 230000012010 growth Effects 0.000 claims description 19
- 239000011159 matrix material Substances 0.000 claims description 14
- 230000000877 morphologic effect Effects 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 230000005484 gravity Effects 0.000 claims description 3
- 230000014509 gene expression Effects 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 5
- 206010006187 Breast cancer Diseases 0.000 description 17
- 208000026310 Breast neoplasm Diseases 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 201000011510 cancer Diseases 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 238000004393 prognosis Methods 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 230000001575 pathological effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000004791 biological behavior Effects 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 238000013145 classification model Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002055 immunohistochemical effect Effects 0.000 description 3
- 101150029707 ERBB2 gene Proteins 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011337 individualized treatment Methods 0.000 description 2
- 208000024312 invasive carcinoma Diseases 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 238000013115 immunohistochemical detection Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000004933 in situ carcinoma Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000026535 luminal A breast carcinoma Diseases 0.000 description 1
- 208000026534 luminal B breast carcinoma Diseases 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 208000022679 triple-negative breast carcinoma Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
- G06F18/20—Analysing
- G06F18/23—Clustering techniques
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/10—Segmentation; Edge detection
- G06T7/11—Region-based segmentation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/10—Segmentation; Edge detection
- G06T7/187—Segmentation; Edge detection involving region growing; involving region merging; involving connected component labelling
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/10—Segmentation; Edge detection
- G06T7/194—Segmentation; Edge detection involving foreground-background segmentation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/60—Analysis of geometric attributes
- G06T7/66—Analysis of geometric attributes of image moments or centre of gravity
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30096—Tumor; Lesion
Landscapes
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- General Physics & Mathematics (AREA)
- Data Mining & Analysis (AREA)
- General Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Evolutionary Computation (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Artificial Intelligence (AREA)
- Life Sciences & Earth Sciences (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Quality & Reliability (AREA)
- Geometry (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Image Analysis (AREA)
Abstract
Description
技术领域technical field
本发明属于医学图像处理技术领域,具体涉及一种基于影像组学的肿瘤分型方法。The invention belongs to the technical field of medical image processing, and in particular relates to a radiomics-based tumor typing method.
背景技术Background technique
随着人类平均寿命的延长,癌症对人类的威胁日益突出,已经成为我国城乡居民的第一位死因。以乳腺癌为例,乳腺癌是指乳腺导管上皮发生的恶性肿瘤,为妇女最常见的恶性肿瘤之一,发病率为23/10万,占全身各种恶性肿瘤的7~10%,发病高峰在45-55岁之间,且呈逐年上升的趋势,尤其沪、京、津及沿海地区是我国乳腺癌的高发地区。乳腺癌筛查和早诊制度的建立能有效降低死亡率,更得益于近年来不断发展的分子生物学技术和综合诊疗规范化水平的提高。With the prolongation of the average life expectancy of human beings, the threat of cancer to human beings has become increasingly prominent, and it has become the first cause of death of urban and rural residents in our country. Taking breast cancer as an example, breast cancer refers to malignant tumors occurring in breast ductal epithelium. It is one of the most common malignant tumors in women, with an incidence rate of 23/100,000, accounting for 7-10% of all kinds of malignant tumors in the whole body. Between the ages of 45 and 55, and showing an increasing trend year by year, especially Shanghai, Beijing, Tianjin and the coastal areas are the high incidence areas of breast cancer in my country. The establishment of breast cancer screening and early diagnosis system can effectively reduce the mortality rate, and it also benefits from the continuous development of molecular biology technology and the improvement of the standardization level of comprehensive diagnosis and treatment in recent years.
肿瘤分型是对肿瘤进行诊断、判断预后、选择治疗方法以及进行各项研究的基础,因此,建立准确有效的肿瘤分类体系是关键。迄今为止,肿瘤的分类主要还是以组织病理学为基础的形态学分类(即:病理分型)。恶性肿瘤在分子水平上高度异质,形态相同的肿瘤其分子遗传学改变未必一致,从而导致肿瘤的预后及对治疗的反应差别很大。因此,研究者还提出了基因分型、临床分型、免疫组化分型等方法,以便能更精确的判断肿瘤的生物学行为、估计预后并选择或研究更有针对性的个性化治疗方法。常见几种肿瘤分型划分方法:Tumor classification is the basis for diagnosing tumors, judging prognosis, choosing treatment methods, and conducting various researches. Therefore, establishing an accurate and effective tumor classification system is the key. So far, tumor classification is mainly morphological classification based on histopathology (ie: pathological typing). Malignant tumors are highly heterogeneous at the molecular level, and the molecular genetic changes of tumors with the same morphology may not be consistent, resulting in great differences in the prognosis and response to treatment of tumors. Therefore, researchers have also proposed methods such as genotyping, clinical typing, and immunohistochemical typing in order to more accurately judge the biological behavior of tumors, estimate prognosis, and select or study more targeted personalized treatment methods. . Several common tumor classification methods:
病理分型:根据病理分型将乳腺癌分为非浸润性癌、早期浸润癌、浸润癌。国际WHO组织分类为非浸润性癌和浸润性癌。Pathological classification: According to pathological classification, breast cancer is divided into non-invasive carcinoma, early invasive carcinoma, and invasive carcinoma. International WHO classification into non-invasive cancer and invasive cancer.
基因分型:采用基因微阵列分析技术将乳腺癌分为Luminal A型、Luminal B型、HER-2过表达型、Basal-like基底样型和Normal-like正常细胞样型。Genotyping: Breast cancer was divided into Luminal A type, Luminal B type, HER-2 overexpression type, Basal-like basal-like type and Normal-like normal cell-like type by gene microarray analysis technology.
临床分型:临床常见的分类包括激素受体阳性、HER2/neu受体阳性、三阴性乳腺癌(ER、PR、HER2/neu均为阴性)。Clinical classification: Common clinical classifications include hormone receptor positive, HER2/neu receptor positive, triple negative breast cancer (ER, PR, HER2/neu are all negative).
免疫组化分型:根据ER、PR、HER-2和Ki-67进行分类为官腔上皮型、HER2过表达型和基底样型。Immunohistochemical typing: According to ER, PR, HER-2 and Ki-67, it was classified into luminal epithelial type, HER2 overexpression type and basal-like type.
乳腺癌是一类高度异质性肿瘤,组织学形态多种多样。异质性肿瘤是指肿瘤在生长过程中,经过多次分裂增殖,其子细胞呈现出分子生物学或基因方面的改变,从而使肿瘤的生长速度、侵袭能力、对药物的敏感性、预后等各方面产生差异。简单说就是同一肿瘤中可以存在有很多不同的基因型或者亚型的细胞。因此同一种肿瘤在不同的个体身上可表现出不一样的治疗效果及预后,甚至同一个体身上的肿瘤细胞也存在不同的特性和差异。乳腺癌的异质性决定了各亚型特有的临床病理学特点,也决定了各亚型的预后。乳腺癌的发生发展不仅在病理方面有异质性,在遗传及基因表型等方面也有异质性,因此,病理类型结合免疫组化分型已成为目前乳腺癌诊断的常规手段。Breast cancer is a highly heterogeneous tumor with various histological forms. Heterogeneous tumors refer to tumors that have undergone multiple divisions and proliferations during the growth process, and their daughter cells exhibit molecular biological or genetic changes, which can lead to changes in tumor growth rate, invasion ability, drug sensitivity, prognosis, etc. There are differences in all aspects. Simply put, there can be many different genotypes or subtypes of cells in the same tumor. Therefore, the same tumor can show different therapeutic effects and prognosis in different individuals, and even tumor cells in the same individual have different characteristics and differences. The heterogeneity of breast cancer determines the unique clinicopathological characteristics of each subtype and also determines the prognosis of each subtype. The occurrence and development of breast cancer is heterogeneous not only in pathology, but also in genetics and gene phenotype. Therefore, pathological type combined with immunohistochemical typing has become a routine method for breast cancer diagnosis.
虽然上述分类方法对乳腺癌的预后判断和治疗方案的选择具有较高的指导价值,且基因表达谱和基因芯片为基础的乳腺癌基因分型虽初步能反映肿瘤的生物学行为,但仍存在一定问题。乳腺癌异质性的存在,其在组织形态、免疫表型、生物学行为及治疗反应上存在着极大的差异。临床病理诊断,一般采用穿刺或手术活检,不仅对身体造成创伤,还表现出一定的局限性,同区域病理形态可能不同,不同区域其分化程度可能差别很大;同理,乳腺癌异质性也可能使得通过基因芯片技术得到的分子分型和免疫组化法检测结果不完全一致。因此,人们期待找到能够通用的分型方法,以用于指导临床,为解决肿瘤的异质性提供理论依据,为患者提供更好的个体化治疗方案都具有非常重要的意义。Although the above classification methods have a high guiding value for the prognosis of breast cancer and the selection of treatment options, and the gene expression profile and gene microarray-based breast cancer genotyping can initially reflect the biological behavior of the tumor, but there are still There must be a problem. The existence of breast cancer heterogeneity, there are great differences in histological morphology, immunophenotype, biological behavior and treatment response. Clinicopathological diagnosis generally uses puncture or surgical biopsy, which not only causes trauma to the body, but also shows certain limitations. The pathological morphology of the same region may be different, and the degree of differentiation may vary greatly in different regions; similarly, the heterogeneity of breast cancer It may also make the molecular typing and immunohistochemical detection results obtained by gene chip technology not completely consistent. Therefore, it is of great significance to find a general classification method to guide clinical practice, provide a theoretical basis for solving tumor heterogeneity, and provide better individualized treatment options for patients.
发明内容Contents of the invention
本发明针对现有技术存在的问题提供一种基于影像组学的肿瘤分型方法,称为影像分型方法,本发明肿瘤分型方法,其具有无创性、非介入、可重复等优点,且其分析对象基于全部病灶组织,信息全面性高。本发明:Aiming at the problems existing in the prior art, the present invention provides a radiomics-based tumor typing method, which is called an imaging typing method. The tumor typing method of the present invention has the advantages of non-invasiveness, non-intervention, repeatability, etc., and The analysis object is based on all lesion tissues, and the information is comprehensive. this invention:
(1)提出了基于影像组学的肿瘤分型方法,提出了异质区域提取方法,构建了影像分型组;(1) A radiomics-based tumor classification method was proposed, a heterogeneous region extraction method was proposed, and an image classification group was constructed;
(2)提出了基于该影像分型组判定新病灶的分型方法,并可与现有病理分型、临床分型、分子分型等其他分型方法进行对照评判。本发明给出了与分子分型进行对照的效果对比。(2) A classification method for judging new lesions based on the image classification group is proposed, which can be compared with other classification methods such as the existing pathological classification, clinical classification, and molecular classification. The present invention provides a comparison of effects compared with molecular typing.
技术方案如下:The technical solution is as follows:
一种基于影像组学的肿瘤分型方法,其中包括:A radiomics-based approach to tumor typing that includes:
病灶区域提取,用于提取精准的病灶数据,其流程包括寻找种子点和病灶区域生长;Lesion area extraction, used to extract accurate lesion data, the process includes finding seed points and lesion area growth;
异质区域提取,采用聚类方法提取出该精准病灶数据中所有的初始异质区域,然后根据类簇在图像上的连通性和像素个数判定最后的聚类结果,找出多个异质区域;Heterogeneous region extraction, using the clustering method to extract all the initial heterogeneous regions in the precise lesion data, and then judging the final clustering results according to the connectivity and number of pixels of the clusters on the image, to find out multiple heterogeneous regions area;
参数向量提取,针对提取的异质区域数据集,提取每一个异质区的形态、状态等参数,组成参数向量矩阵;Parameter vector extraction, for the extracted heterogeneous area data set, extract the shape, state and other parameters of each heterogeneous area to form a parameter vector matrix;
分型组提取,针对参数向量矩阵的每一行,即一个异质区,采用聚类方法对每一个异质区进行类簇划分,聚类后得到多个类别,记作分型组;Typing group extraction, for each row of the parameter vector matrix, that is, a heterogeneous area, the clustering method is used to divide each heterogeneous area into clusters, and multiple categories are obtained after clustering, which are recorded as typing groups;
新病灶分型判定,用来判断新病灶每一个异质区分型属于哪一类型,新病灶经过新病灶区域提取与新病灶异质区域提取后,根据分型组提取结果,判定新病灶每个异质区属于哪类分型;The new lesion type determination is used to determine which type each heterogeneous type of the new lesion belongs to. After the new lesion area extraction and the new lesion heterogeneous area extraction, according to the classification group extraction results, determine the type of each new lesion. Which type of heterogeneous area belongs to;
新病灶分型结果,用来输出新病灶分型结果,新病灶每个异质区分型向量的和为新病灶的分型结果。The typing result of the new lesion is used to output the typing result of the new lesion, and the sum of each heterogeneous distinguishing vector of the new lesion is the typing result of the new lesion.
所述病灶区域提取中寻找种子点包括:Finding the seed point in the lesion area extraction includes:
(1)图像二值化:将原图像中的前景和背景区分开来;(1) Image binarization: distinguish the foreground and background in the original image;
(2)去除噪声点:开运算去除图像中的白噪声,闭运算去除图像中的小空洞;(2) Remove noise points: open operation to remove white noise in the image, and close operation to remove small holes in the image;
(3)距离计算:经步骤(1)和步骤(2)处理后图像中非零像素点到最近的0像素的距离;(3) distance calculation: the distance from the non-zero pixel in the image to the nearest 0 pixel after step (1) and step (2);
(4)质心获取:在所有距离中找到最大距离所对应的点的坐标,即种子点。(4) Acquisition of centroid: Find the coordinates of the point corresponding to the maximum distance among all distances, that is, the seed point.
所述病灶区域生长包括:The growth of the lesion area includes:
寻找的种子点;以种子点为中心,考虑种子点的8邻域像素,如果种子点满足生长准则,将邻域像素与该种子点合并在同一区域内;当点都有归属,生长结束。The seed point to find; take the seed point as the center, consider the 8 neighboring pixels of the seed point, if the seed point satisfies the growth criterion, merge the neighboring pixels with the seed point in the same area; when all the points belong to, the growth ends.
所述生长准则包括:The growth guidelines include:
准则1:判断邻域像素和当前像素的像素值差的绝对值是否小于差值阈值Ts;Criterion 1: Determine whether the absolute value of the pixel value difference between the neighboring pixel and the current pixel is less than the difference threshold Ts;
准则2:判断邻域像素的像素值大小是否满足生长所需的像素阈值Tp;Criterion 2: Judging whether the pixel value of the neighboring pixels meets the pixel threshold Tp required for growth;
所述异质区域提取步骤包括,The heterogeneous region extraction step includes,
(1)基于输入病灶数据,找到图像中灰度值非0的像素坐标和灰度值,组织成一个三元组列表;(1) Based on the input lesion data, find pixel coordinates and gray values with non-zero gray values in the image, and organize them into a list of triplets;
(2)利用聚类算法对三元组列表进行聚类,分别测试从2~10不同的类簇个数,利用肘部规则确定最优的类簇个数,并输出聚类初步结果;(2) Use the clustering algorithm to cluster the list of triples, test the number of clusters from 2 to 10 respectively, use the elbow rule to determine the optimal number of clusters, and output the preliminary clustering results;
(3)针对上述聚类结果判断每一个类簇内是否连通,如果不连通将该类簇进行分裂为若干最大的连通子类簇;判断是否连通是根据类簇内像素点在平面上是否邻接或者存在邻接通路;(3) According to the above clustering results, judge whether each cluster is connected. If not, split the cluster into several largest connected sub-clusters; whether the connection is judged is based on whether the pixels in the cluster are adjacent on the plane. Or there is an adjacent path;
(4)针对上述每一个连通的类簇,判断类簇内像素总数,如果总数小于某一经验值,就丢弃该类簇,否则保留,作为最终异质区集合。(4) For each of the above-mentioned connected clusters, judge the total number of pixels in the cluster. If the total number is less than a certain empirical value, discard the cluster; otherwise, keep it as the final set of heterogeneous regions.
所述参数向量提取包括纹理参数、动力学参数、统计参数、形态参数和临床参数。The parameter vector extraction includes texture parameters, dynamic parameters, statistical parameters, morphological parameters and clinical parameters.
所述新病灶的分型判定包括,新病灶的异质区域,与分型组提取结果得到的多个类别的中心点取相似函数,这里相似函数取欧式距离,距离越小表示该新病灶的异质区属于该类簇的可能性越大,这里中心点是根据该类簇中所有异质区向量计算出来的重心。The classification determination of the new lesion includes taking a similarity function between the heterogeneous area of the new lesion and the center points of multiple categories obtained from the extraction result of the typing group. The more likely the heterogeneous area belongs to the cluster, the center point here is the center of gravity calculated based on the vectors of all heterogeneous areas in the cluster.
所述新病灶每个异质区分型向量为,新病灶每个异质区的分型结果表示为一个布尔向量,属于该类的对应位置为1,其他为0,称为分型向量。The typing vector of each heterogeneous area of the new lesion is , the typing result of each heterogeneous area of the new lesion is expressed as a Boolean vector, the corresponding position belonging to this class is 1, and the other is 0, which is called the typing vector.
其有益效果是:Its beneficial effect is:
本发明提出了一种新的肿瘤分型方法影像分型方法,其考虑信息全面,针对全部病灶组织,具有无创、非介入、可重复性好等优点。针对一些高度异质性肿瘤,例如乳腺癌,其准确分型有利于指导临床,为解决肿瘤的异质性提供理论依据,并为患者提供更好的个体化治疗方案。The present invention proposes a new tumor classification method, which considers comprehensive information, targets all lesion tissues, and has the advantages of non-invasive, non-intervention, and good repeatability. For some highly heterogeneous tumors, such as breast cancer, its accurate classification is conducive to guiding clinical practice, providing a theoretical basis for solving tumor heterogeneity, and providing better individualized treatment options for patients.
附图说明Description of drawings
图1为影像分型模型构建流程图,(a)新病灶分型判定,(b)影像分型组构建Figure 1 is the flow chart of image typing model construction, (a) determination of new lesion typing, (b) image typing group construction
图2为影像分型组构建过程;Figure 2 is the construction process of the image typing group;
图3为病灶区域种子点获取流程图;Fig. 3 is the flow chart of obtaining the seed point of the lesion area;
图4为病灶区域生长流程图;Figure 4 is a flowchart of the growth of the lesion area;
图5为异质区域提取流程图;Fig. 5 is a flowchart of heterogeneous region extraction;
图6为肘部规则示意图;Figure 6 is a schematic diagram of the elbow rule;
图7为异质区域提取结果图,(a)基于数据Alesion聚类获得初步结果,(b)类簇连通判断划分为多个子区域;Figure 7 is a diagram of the heterogeneous region extraction results, (a) the preliminary results are obtained based on the data A lesion clustering, (b) the cluster connectivity judgment is divided into multiple sub-regions;
图8为分型组划分示例图;Fig. 8 is an example figure of classification group division;
图9为病灶分型数据示例。Figure 9 is an example of lesion typing data.
具体实施方式Detailed ways
本发明影像分型模型构建流程如图1所示。该过程分为两个过程:影像分型组构建过程和新病灶分型过程,其中提取病灶区域、提取异质区域操作在上述两个过程中技术一致。The construction process of the image classification model of the present invention is shown in Fig. 1 . This process is divided into two processes: the process of image typing group construction and the process of new lesion typing, in which the operations of extracting lesion areas and extracting heterogeneous areas are the same in the above two processes.
一,影像分型组构建过程1. The process of image typing group construction
影像分型组构建过程如图1(b)所示。基于大量乳腺癌感兴趣区(ROI,Region ofInterest)影像数据,首先提取病灶区域数据A,然后针对数据A提取异质区域,对每一个异质区域提取纹理、动力、形态、统计等参数构建多维向量,采用相似性聚类方法将这些异质区域划分为K个集合,每一个类簇集合记为影像分型组,K个集合中心记为影像分型中心,如图2所示。下面分别对这个四个过程进行描述。The construction process of the image typing group is shown in Figure 1(b). Based on a large number of breast cancer ROI (Region of Interest) image data, first extract the lesion area data A, and then extract heterogeneous areas for data A, extract texture, dynamics, shape, statistics and other parameters for each heterogeneous area to construct multi-dimensional The similarity clustering method is used to divide these heterogeneous regions into K sets, each set of clusters is recorded as an image typing group, and the center of K sets is recorded as an image typing center, as shown in Figure 2. The four processes are described below.
1)病灶区域提取1) Lesion area extraction
原始输入的ROI影像数据是在医生的协助下识别影像中的病灶区域,然后通过人工标记ROI区域,即用矩形标记病灶的大致区域获得。基于这样的ROI影像数据(表示为一个数据矩阵),首先计算中心点,即数据矩阵A如下所示:The original input ROI image data is obtained by identifying the lesion area in the image with the assistance of a doctor, and then manually marking the ROI area, that is, marking the approximate area of the lesion with a rectangle. Based on such ROI image data (expressed as a data matrix), first calculate the center point, that is, the data matrix A is as follows:
其中m和n分别代表ROI的高和宽,pij表示该像素点的灰度值。对每一个区域要先指定一个种子点作为生长的起点,该种子点获取ROI中质心过程,如图3所示。Among them, m and n represent the height and width of the ROI respectively, and p ij represents the gray value of the pixel. For each region, a seed point must be designated as the starting point of growth, and the seed point obtains the centroid process in the ROI, as shown in Figure 3.
(1)图像二值化:将前景和背景区分开来。即矩阵A中所有大于阈值T0的像素全为255,小于T0的全为0。T0取A中数据平均值。(1) Image binarization: distinguish the foreground from the background. That is, all pixels greater than the threshold T 0 in matrix A are 255, and all pixels smaller than T 0 are 0. T0 takes the average value of the data in A.
(2)去除噪声点:开运算去除图像中的白噪声,闭运算去除图像中的小空洞。(2) Remove noise points: open operation removes white noise in the image, and close operation removes small holes in the image.
(3)距离计算:经步骤1和步骤2处理后图像A中非零像素点到最近的0像素的距离(3) Distance calculation: the distance from the non-zero pixel in image A to the nearest 0 pixel after step 1 and step 2
(4)质心获取:在所有距离中找到最大距离所对应的点的坐标,即ROI的质心,也就是我们所找的种子点。(4) Acquisition of the centroid: find the coordinates of the point corresponding to the maximum distance among all the distances, that is, the centroid of the ROI, which is the seed point we are looking for.
基于上述种子点,进行区域生长,进而获得精确的病灶区域,过程如图4所示。Based on the above seed points, region growing is carried out to obtain precise lesion regions. The process is shown in Figure 4.
病灶区域生长步骤如下:The steps of lesion area growth are as follows:
(1)寻找的种子点设为(x0,y0),建立掩模矩阵(mask),矩阵和ROI大小一致,除(x0,y0)点外,其他都设为0,mask[x0,y0]=1;(1) The searched seed point is set to (x 0 , y 0 ), and the mask matrix (mask) is established. The size of the matrix and the ROI are the same. Except for the point (x 0 , y 0 ), all others are set to 0, and the mask[ x 0 ,y 0 ]=1;
(2)以(x0,y0)为中心,考虑(x0,y0)的8邻域像素(x,y),如果(x0,y0)满足生长准则(2.1和2.2准则),将(x,y)与(x0,y0)合并(在同一区域内),同时mask[x,y]=1并将该点压入堆栈中;(2) With (x 0 , y 0 ) as the center, consider the 8 neighboring pixels (x, y) of (x 0 , y 0 ), if (x 0 , y 0 ) satisfies the growth criterion (2.1 and 2.2 criteria) , merge (x,y) with (x 0 ,y 0 ) (in the same area), and mask[x,y]=1 and push the point into the stack;
–2.1准则:判断邻域像素和当前像素的像素值差的绝对值是否小于差值阈值Ts,实施过程取Ts=20;-2.1 Criterion: determine whether the absolute value of the pixel value difference between the neighboring pixel and the current pixel is less than the difference threshold Ts, and take Ts=20 in the implementation process;
–2.1准则:判断邻域像素的像素值大小是否满足生长所需的像素阈值Tp,实施过程Tp=像素平均值-20;– 2.1 Criterion: Judging whether the pixel value of neighboring pixels meets the pixel threshold Tp required for growth, the implementation process Tp=pixel average value-20;
(3)从堆栈中取出一个像素,把它当作(x0,y0)返回到步骤(2);(3) Take a pixel from the stack, treat it as (x 0 , y 0 ) and return to step (2);
(4)当堆栈为空时表示所有ROI中的点都有归属,生长结束(4) When the stack is empty, it means that all the points in the ROI have ownership, and the growth ends
基于获取的掩模矩阵mask,将mask与数据矩阵A做运算得到病灶数据矩阵Alesion,即:Based on the acquired mask matrix mask, make mask and data matrix A The lesion data matrix A lesion is obtained by operation, namely:
其中运算符表示:所有mask中为零的点,Alesion中对应位置也置为零,非零点对应Alesion中位置数据为A中对应位置数据。in The operator means: for all points that are zero in the mask, the corresponding position in A lesion is also set to zero, and the position data in A lesion corresponding to non-zero points is the corresponding position data in A.
2)异质区域提取2) Heterogeneous region extraction
基于提取的病灶数据Alesion,采用聚类方法(如K-means)提取出该病灶中所有的初始异质区域,然后根据类簇在图像上的连通性和像素个数判定最后的聚类结果,该提取过程如图5所示。Based on the extracted lesion data A lesion , use a clustering method (such as K-means) to extract all the initial heterogeneous regions in the lesion, and then determine the final clustering result according to the connectivity of the clusters on the image and the number of pixels , the extraction process is shown in Figure 5.
异质区域提取步骤如下:The heterogeneous region extraction steps are as follows:
(1)基于输入病灶数据Alesion,找到图像中灰度值非0的像素坐标和灰度值,组织成一个三元组列表L;(1) Based on the input lesion data A lesion , find pixel coordinates and gray values with non-zero gray values in the image, and organize them into a triplet list L;
(2)利用聚类算法(如K-means)对数据L进行聚类,分别测试从2~10不同的类簇个数,利用肘部规则确定最优的类簇个数Kbest(如图6所示原理);并输出聚类初步结果,如图7(a)所示,基于数据Alesion聚类获得初步结果,这里最优的K取值为2;其中,图6肘部规则示意图,其中横坐标为K值,纵坐标为聚类目标函数(或代价函数)。选择图像中前后斜率变化最大的点的横坐标作为最优K值,如图中K=3即为所求。(2) Use a clustering algorithm (such as K-means) to cluster the data L, test the number of different clusters from 2 to 10, and use the elbow rule to determine the optimal number of clusters K best (as shown in 6); and output the preliminary results of clustering, as shown in Figure 7(a), the preliminary results are obtained based on the data A lesion clustering, where the optimal value of K is 2; among them, the schematic diagram of the elbow rule in Figure 6 , where the abscissa is the K value, and the ordinate is the clustering objective function (or cost function). Select the abscissa of the point with the largest front and rear slope changes in the image as the optimal K value, as shown in the figure, K=3 is the desired value.
(3)针对上述聚类结果判断每一个类簇内是否连通,如果不连通讲该类簇进行分裂为若干最大的连通子类簇;判断是否连通是根据类簇内像素点在平面上是否邻接或者存在邻接通路;(3) According to the above clustering results, it is judged whether each cluster is connected. If it is not connected, the cluster is split into several largest connected sub-clusters; whether the connection is judged is based on whether the pixels in the cluster are adjacent on the plane. Or there is an adjacent path;
(4)针对上述每一个连通的类簇,判断类簇内像素总数,如果总数小于10(经验值,可根据实际病种进行调节)就丢弃该类簇,否则保留,作为最终异质区集合Φ中一个异质区如图7(b)所示,类簇连通判断划分为多个子区域,删除像素数小于10的类簇。这里类簇数为4,即Alesion矩阵转化为4个数据矩阵 (4) For each of the above connected clusters, determine the total number of pixels in the cluster, and if the total number is less than 10 (experience value, can be adjusted according to the actual disease type), discard the cluster, otherwise keep it as the final set of heterogeneous regions A heterogeneous region in Φ As shown in Figure 7(b), the cluster connectivity judgment is divided into multiple sub-regions, and the clusters with less than 10 pixels are deleted. The number of clusters here is 4, that is, the A lesion matrix is converted into 4 data matrices
3)参数向量提取3) Parameter vector extraction
针对提取的异质区数据集Φ,提取每一个异质区的形态、形状等参数,其中本申请提取了参数包括纹理参数、动力学参数、统计参数、形态参数和临床参数,上述参数计算方法如表1所示。For the extracted heterogeneous area data set Φ, extract each heterogeneous area parameters such as shape and shape, among which The parameters extracted in this application include texture parameters, dynamic parameters, statistical parameters, morphological parameters and clinical parameters. The calculation methods of the above parameters are shown in Table 1.
表1.异质区参数计算方法Table 1. Calculation method of heterogeneous region parameters
以上所有参数计算完成后,其维数之和共计62维,根据不同肿瘤类型提取相应参数个数也不同,得到的维数也是不同的,记作D(D=62)。假设异质区个数为H,每一个异质区提取出一个参数向量ω,提取后的参数向量组成矩阵Ω大小为D*H,即:After the calculation of all the above parameters is completed, the sum of the dimensions is 62 dimensions. The number of corresponding parameters extracted according to different tumor types is also different, and the obtained dimension is also different, which is recorded as D (D=62). Assuming that the number of heterogeneous regions is H, a parameter vector ω is extracted from each heterogeneous region, and the size of the extracted parameter vector matrix Ω is D*H, namely:
4)分型组提取4) Typing group extraction
上述参数向量异质区数据Ω的每一行代表一个异质区,本申请采用聚类方法对每一个异质区进行类簇划分,这里聚类方法采用K均值(这里K取经验值)。聚类后得到K个类别,每个类别的中心向量为:Y=(C1,C2,...,CK),如图8所示:Each row of the heterogeneous area data Ω of the parameter vector above represents a heterogeneous area. This application uses a clustering method to divide each heterogeneous area into clusters. Here, the clustering method uses K-means (where K is an empirical value). K categories are obtained after clustering, and the center vector of each category is: Y=(C 1 , C 2 ,..., C K ), as shown in Figure 8:
这里的每一个中心向量是根据该类簇中所有异质区向量计算出来的重心。Each center vector here is the center of gravity calculated according to all heterogeneous region vectors in the cluster.
二,新病灶分型过程2. The process of typing new lesions
判断一个新的异质区(参数向量v)属于哪个分型组可通过计算如下公式。取相似度最大的那个类别作为该异质区的类组。Judging which typing group a new heterogeneous area (parameter vector v) belongs to can be calculated by the following formula. The category with the largest similarity is taken as the category group of the heterogeneous area.
其中:1≤k≤K Where: 1≤k≤K
Sim是衡量v与每一个中心点的相似性函数,通常这里取欧式距离,距离越小表示该异质区属于该类簇的可能性越大。Sim is a measure of the similarity function between v and each center point. Usually, the Euclidean distance is used here. The smaller the distance, the greater the possibility that the heterogeneous area belongs to the cluster.
基于上述计算方法,每一个异质区的分型类型表示一个布尔向量S:Based on the above calculation method, the typing type of each heterogeneous area represents a Boolean vector S:
S=(01,...,1k′,...,0K)S=(0 1 ,...,1 k ′,...,0 K )
即属于k’类的对应位置为1,其他为0,称为分型向量。一个病灶ROI区域有多个异质区,每一个异质区都可计算得到一个分型向量。假设一个病灶ROI区域有t个异质区,那么该病灶分型向量为各个异质区分型向量的和,即:That is, the corresponding position belonging to the k' class is 1, and the others are 0, which is called the classification vector. A lesion ROI region has multiple heterogeneous regions, and each heterogeneous region can be calculated to obtain a typing vector. Assuming that there are t heterogeneous regions in a lesion ROI region, then the lesion typing vector is the sum of all heterogeneous distinguishing vectors, namely:
三,方法验证Three, method validation
本发明验证数据集大小636个乳腺癌ROI数据,按照分子分型划分:LA型162例,LB型162例,HER-2型153例,Basic-like型159例,这些类型已经经过活检病理验证;把这些数据分为两个集合,一部分是训练集477例,剩下作为测试集159例,每一个病灶提取的分型数据如图9所示,这里取k=10。The verification data set size of the present invention is 636 breast cancer ROI data, which are divided according to molecular types: 162 cases of LA type, 162 cases of LB type, 153 cases of HER-2 type, and 159 cases of Basic-like type. These types have been verified by biopsy pathology Divide these data into two sets, one part is the training set of 477 cases, and the rest is used as the test set of 159 cases. The typing data extracted from each lesion is shown in Figure 9, and k=10 is taken here.
选择GBDT、XGBboost和MLP数据分类模型,以分子分型作为分类标签,以影像分型向量作为模型输入,采用交叉测试方式验证预测准确性,如表2所示。The GBDT, XGBboost and MLP data classification models were selected, the molecular typing was used as the classification label, the image typing vector was used as the model input, and the prediction accuracy was verified by cross-testing, as shown in Table 2.
表2预测准确性Table 2 Prediction accuracy
通过上述测试结果来看,影像分型的划分和分子分型达到最高83.13%对照准确性,16.87%的错误原因来自两个方面:一是分类模型本身存在误差;二是分子分型是精确划分(四类中一类),取决于局部活检组织类型,而影像分型是整体病灶进行分型划分,非精确划分,综合了不同异质区的实际特点而判定,因此第二类错误原因并不能说明影像分型的分析结果存在问题。According to the above test results, the division of image typing and molecular typing reached the highest comparison accuracy of 83.13%, and the 16.87% error came from two aspects: one is that there is an error in the classification model itself; the other is that molecular typing is an accurate division (One of the four categories), depending on the type of local biopsy tissue, and the imaging classification is based on the classification of the overall lesion, which is imprecise and determined based on the actual characteristics of different heterogeneous areas. Therefore, the second type of error does not It cannot explain that there is a problem with the analysis results of image typing.
综上分析,本发明的影像分型方法具有无创、非介入、可重复性好优点,且分析对象基于全部病灶组织,而非局限在局部(如穿刺、基因切片等),信息全面性高,不失是一种新的、先进的肿瘤分型方法。In summary, the image typing method of the present invention has the advantages of non-invasive, non-interventional, and good repeatability, and the analysis object is based on the whole lesion tissue, not limited to the local area (such as puncture, gene slice, etc.), and the information is comprehensive. It is a new and advanced tumor classification method.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810566664.2A CN108765411B (en) | 2018-06-05 | 2018-06-05 | A radiomics-based tumor typing system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810566664.2A CN108765411B (en) | 2018-06-05 | 2018-06-05 | A radiomics-based tumor typing system |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108765411A true CN108765411A (en) | 2018-11-06 |
CN108765411B CN108765411B (en) | 2021-01-12 |
Family
ID=63998865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810566664.2A Active CN108765411B (en) | 2018-06-05 | 2018-06-05 | A radiomics-based tumor typing system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108765411B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110210495A (en) * | 2019-05-21 | 2019-09-06 | 浙江大学 | The XGBoost soft-measuring modeling method extracted based on parallel LSTM self-encoding encoder behavioral characteristics |
CN111445946A (en) * | 2020-03-26 | 2020-07-24 | 北京易康医疗科技有限公司 | An Algorithm for Calculating Lung Cancer Genotyping Using PET/CT Images |
CN113808090A (en) * | 2021-09-08 | 2021-12-17 | 中国科学院深圳先进技术研究院 | Magnetic resonance image processing method, terminal device and computer storage medium |
CN114066882A (en) * | 2021-12-14 | 2022-02-18 | 中南大学 | Lung adenocarcinoma Ki67 expression level non-invasive detection method and device based on depth imaging omics |
CN114999569A (en) * | 2022-08-03 | 2022-09-02 | 北京汉博信息技术有限公司 | A kind of typing method, device and computer readable medium for lesion matrix |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103353987A (en) * | 2013-06-14 | 2013-10-16 | 山东大学 | Superpixel segmentation method based on fuzzy theory |
CN104851101A (en) * | 2015-05-25 | 2015-08-19 | 电子科技大学 | Brain tumor automatic segmentation method based on deep learning |
CN104933711A (en) * | 2015-06-10 | 2015-09-23 | 南通大学 | Automatic fast segmenting method of tumor pathological image |
CN106202969A (en) * | 2016-08-01 | 2016-12-07 | 东北大学 | A kind of tumor cells typing prognoses system |
US20170270660A1 (en) * | 2016-03-02 | 2017-09-21 | Flagship Biosciences, Inc. | Method for assigning tissue normalization factors for digital image analysis |
-
2018
- 2018-06-05 CN CN201810566664.2A patent/CN108765411B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103353987A (en) * | 2013-06-14 | 2013-10-16 | 山东大学 | Superpixel segmentation method based on fuzzy theory |
CN104851101A (en) * | 2015-05-25 | 2015-08-19 | 电子科技大学 | Brain tumor automatic segmentation method based on deep learning |
CN104933711A (en) * | 2015-06-10 | 2015-09-23 | 南通大学 | Automatic fast segmenting method of tumor pathological image |
US20170270660A1 (en) * | 2016-03-02 | 2017-09-21 | Flagship Biosciences, Inc. | Method for assigning tissue normalization factors for digital image analysis |
CN106202969A (en) * | 2016-08-01 | 2016-12-07 | 东北大学 | A kind of tumor cells typing prognoses system |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110210495A (en) * | 2019-05-21 | 2019-09-06 | 浙江大学 | The XGBoost soft-measuring modeling method extracted based on parallel LSTM self-encoding encoder behavioral characteristics |
CN110210495B (en) * | 2019-05-21 | 2021-05-04 | 浙江大学 | XGBoost Soft Sensing Modeling Method Based on Parallel LSTM Autoencoder Dynamic Feature Extraction |
CN111445946A (en) * | 2020-03-26 | 2020-07-24 | 北京易康医疗科技有限公司 | An Algorithm for Calculating Lung Cancer Genotyping Using PET/CT Images |
CN111445946B (en) * | 2020-03-26 | 2021-07-30 | 山东省肿瘤防治研究院(山东省肿瘤医院) | An Algorithm for Calculating Lung Cancer Genotyping Using PET/CT Images |
CN113808090A (en) * | 2021-09-08 | 2021-12-17 | 中国科学院深圳先进技术研究院 | Magnetic resonance image processing method, terminal device and computer storage medium |
CN114066882A (en) * | 2021-12-14 | 2022-02-18 | 中南大学 | Lung adenocarcinoma Ki67 expression level non-invasive detection method and device based on depth imaging omics |
CN114999569A (en) * | 2022-08-03 | 2022-09-02 | 北京汉博信息技术有限公司 | A kind of typing method, device and computer readable medium for lesion matrix |
CN114999569B (en) * | 2022-08-03 | 2022-12-20 | 北京汉博信息技术有限公司 | Method, device and computer readable medium for typing focus stroma |
Also Published As
Publication number | Publication date |
---|---|
CN108765411B (en) | 2021-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108765411A (en) | A kind of tumor classification method based on image group | |
WO2023078041A1 (en) | Tumor tissue pathological classification system and method based on adaptive proportional learning | |
CN103440665B (en) | Automatic segmentation method of knee joint cartilage image | |
US20080166035A1 (en) | Computer-Aided Pathological Diagnosis System | |
CN108830853A (en) | A kind of melanoma aided diagnosis method based on artificial intelligence | |
CN105719294B (en) | A kind of breast cancer pathological image mitotic nucleus automatic division method | |
CN107563996B (en) | A kind of novel discus nervi optici dividing method and system | |
CN104217213B (en) | A kind of medical image multistage sorting technique based on symmetric theory | |
CN110232410A (en) | The organ-tissue Pathologic image analysis method and analytical equipment of multi-layer | |
CN109033936A (en) | A kind of cervical exfoliated cell core image-recognizing method | |
CN107358611A (en) | A kind of automatic division method of panoramic scanning pathological image transport zone | |
Beevi et al. | Detection of mitotic nuclei in breast histopathology images using localized ACM and Random Kitchen Sink based classifier | |
CN115457069A (en) | Method and device for image-based feature extraction and prognostic model establishment | |
Mohammad et al. | Texture analysis for the segmentation of optic disc in retinal images | |
CN110148126A (en) | Blood leucocyte dividing method based on color component combination and contour fitting | |
CN112614093A (en) | Breast pathology image classification method based on multi-scale space attention network | |
CN116310553A (en) | A method for predicting molecular classification of breast pathological images based on multi-attribute embedding model | |
CN113011257A (en) | Breast cancer immunohistochemical artificial intelligence interpretation method | |
Kowal et al. | Computer-aided diagnosis of breast cancer using Gaussian mixture cytological image segmentation | |
Kim et al. | Nucleus segmentation and recognition of uterine cervical pap-smears | |
Song et al. | Liver segmentation based on SKFCM and improved GrowCut for CT images | |
CN117038060A (en) | Raman spectrum molecular detection and imaging device based on machine learning cascade | |
CN110246125A (en) | Teat placement automatic testing method based on ABUS coronal image | |
Narayan et al. | Cervical Cancer Detection Based on Novel Decision Tree Approach. | |
Lin et al. | Assessment of breast cancer mesenchymal tumor infiltrating lymphocytes based on regional segmentation and nuclear segmentation classification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |